Injectable Traceability: The CQC Requirement Aesthetic Clinics Can’t Ignore

Injectable traceability is now a CQC requirement for UK aesthetic clinics. This guide explains what it means, why it matters for patient safety, and exactly what records you need to maintain.

When a patient has an adverse reaction to a dermal filler, the ability to trace exactly which product was used — from manufacturer to batch number to the specific treatment appointment — can be the difference between a swift resolution and a serious patient safety incident. Injectable traceability isn’t just a regulatory box to tick; it’s a fundamental clinical safeguard.

What Is Injectable Traceability?

Injectable traceability is the practice of linking every injectable treatment administered to a specific product batch. That means recording — and retaining — the following information for each treatment:

  • The product name and manufacturer
  • The batch or lot number printed on the packaging
  • The expiry date of the product used
  • The quantity administered and the treatment area
  • The date of treatment and the patient it was administered to
  • The name of the prescribing clinician

This chain of information — from supplier invoice through to patient record — is what regulators and legal teams mean when they refer to a complete traceability trail.

Why Is It a CQC Requirement?

Under Regulation 12 of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 — Safe Care and Treatment — registered providers must take all reasonable steps to prevent harm. For injectable procedures, this includes the ability to recall treatments if a product is found to be counterfeit, contaminated, or subject to a manufacturer recall.

Without batch-level traceability, a clinic cannot comply with a product recall, cannot investigate an adverse event properly, and cannot demonstrate to a CQC inspector that it has adequate safeguards in place. It is one of the most commonly cited deficiencies in inspection reports for aesthetic clinics.

⚠️ Product recalls do happen. In recent years, several dermal filler batches have been subject to MHRA alerts due to contamination. Clinics without batch records have no way of knowing whether affected products were used on their patients.

How to Set Up a Traceability System

A robust traceability system doesn’t need to be complex — but it does need to be consistent. Here’s a practical framework:

1

Record at the point of purchase

When product arrives, log the batch number, expiry date, supplier and invoice reference. Retain supplier documentation. Never accept products without accompanying documentation.

2

Record at the point of treatment

Before you dispose of the packaging, record the batch number in the patient’s clinical record alongside the treatment date, product name, volume used, and treatment area. This step is non-negotiable.

3

Link batch to patient — permanently

The link between the batch record and the patient record must be permanent and auditable. A spreadsheet with copy-paste entries or paper records that can be lost or altered are not adequate for CQC purposes.

4

Maintain an adverse event log

Any adverse reaction — however minor — should be logged, with the batch number referenced. This allows patterns to be identified and supports MHRA yellow card reporting where required.

5

Retain records for a minimum of 8 years

Clinical records for adults must be retained for a minimum of 8 years from the last treatment date. For minors, records must be kept until their 25th birthday or 8 years after last treatment, whichever is longer.

Common Mistakes Clinics Make

  • Recording only the product name, not the batch number — this is insufficient for a product recall scenario
  • Logging batch data separately from patient records — the link must be direct and searchable
  • Using WhatsApp or notes apps to record batch data — these cannot be audited and data can be deleted
  • Not retaining supplier invoices — invoices corroborate batch records and are required during inspections
  • Failing to record products used during training sessions — training treatments on patients are still clinical treatments

Paper vs Digital: Which Is Better?

Paper-based traceability systems are still technically permissible, but they carry significant practical risk. Paper records can be lost, damaged, or misfiled. They cannot be searched instantly during an inspection. And they create an administrative burden that many small clinics struggle to maintain consistently.

A digital clinical management system that embeds batch recording into the treatment workflow — making it a required field before a record can be saved — eliminates the risk of accidental omission and creates an instantly auditable trail.

Injectable traceability built in — not bolted on

Intentiq’s traceability module links every injectable treatment to a product batch at the point of recording. Fully auditable, CQC-ready, and connected directly to your patient records.

Book a Free Demo →

Similar Posts